| |
 |
ARTICLES 
|
|
| "Biologic" differences in acquired immune deficiency syndrome- associated non-Hodgkin's lymphomas? |
| JL Ziegler |
|
JCO Aug 1 1991: 1329–1331.
[PDF]
|
 |
| Leukemia cell DNA content: predictor of late relapse in acute lymphoblastic leukemia |
| GD Hammond |
|
JCO Aug 1 1991: 1332–1333.
[PDF]
|
|
|
Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency |
| |
SH McDunn, JN Winter, D Variakojis, AW Rademaker, JH Von Roenn, MS Tallman, LI Gordon, and KD Bauer |
| |
JCO Aug 1 1991: 1334–1340.
[Abstract]
[PDF]
|
|
|
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. |
| |
CH Pui, RK Dodge, AT Look, SL George, GK Rivera, M Abromowitch, J Ochs, WE Evans, WM Crist, and JV Simone |
| |
JCO Aug 1 1991: 1341–1347.
[Abstract]
[PDF]
|
|
|
A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation [published erratum appears in J Clin Oncol 1991 Oct;9(10):1922] |
| |
RK Mulhern, D Fairclough, and J Ochs |
| |
JCO Aug 1 1991: 1348–1356.
[Abstract]
[PDF]
|
|
|
The contribution of salvage surgery to the management of childhood osteosarcoma |
| |
U Pastorino, M Gasparini, L Tavecchio, A Azzarelli, S Mapelli, V Zucchi, F Morandi, FF Bellani, M Valente, and G Ravasi |
| |
JCO Aug 1 1991: 1357–1362.
[Abstract]
[PDF]
|
|
|
Interleukin-2 and lymphokine-activated killer cells in 15 children with advanced metastatic neuroblastoma [published erratum appears in J Clin Oncol 1992 Jun;10(6):1026] |
| |
S Negrier, J Michon, D Floret, E Bouffet, JC Gentet, I Philip, P Cochat, D Stamm, J Costil, and M Gaspard |
| |
JCO Aug 1 1991: 1363–1370.
[Abstract]
[PDF]
|
|
|
N-myc genomic content and DNA ploidy in stage IVS neuroblastoma |
| |
J Bourhis, C Dominici, H McDowell, G Raschella, G Wilson, MA Castello, E Plouvier, J Lemerle, G Riou, and J Benard |
| |
JCO Aug 1 1991: 1371–1375.
[Abstract]
[PDF]
|
|
|
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution |
| |
EE Vokes, R Mick, EP Lester, WR Panje, and RR Weichselbaum |
| |
JCO Aug 1 1991: 1376–1384.
[Abstract]
[PDF]
|
|
|
A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium |
| |
V Gregoire, M Beauduin, Y Humblet, M Hamoir, J Longueville, F Majois, FM Remacle, F Rousseau, E Salamon, and A Wambersie |
| |
JCO Aug 1 1991: 1385–1392.
[Abstract]
[PDF]
|
|
|
Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? |
| |
JP Richie and PW Kantoff |
| |
JCO Aug 1 1991: 1393–1396.
[Abstract]
[PDF]
|
|
|
Effect of daily etidronate on the osteolysis of multiple myeloma |
| |
AR Belch, DE Bergsagel, K Wilson, S O'Reilly, J Wilson, D Sutton, J Pater, D Johnston, and B Zee |
| |
JCO Aug 1 1991: 1397–1402.
[Abstract]
[PDF]
|
|
|
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma |
| |
CI Falkson, G Falkson, and HC Falkson |
| |
JCO Aug 1 1991: 1403–1408.
[Abstract]
[PDF]
|
|
|
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP |
| |
DL Longo, PL Duffey, VT DeVita, Jr, PH Wiernik, SM Hubbard, JC Phares, AW Bastian, ES Jaffe, and RC Young |
| |
JCO Aug 1 1991: 1409–1420.
[Abstract]
[PDF]
|
|
|
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity |
| |
JM Vose, PJ Bierman, JR Anderson, D Weisenburger, DF Moravec, S Sorensen, M Hutchins, MD Dowling, D Howe, and J Okerbloom |
| |
JCO Aug 1 1991: 1421–1425.
[Abstract]
[PDF]
|
|
|
Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience |
| |
LW Kwak, M Wilson, LM Weiss, R Doggett, RF Dorfman, RA Warnke, and SJ Horning |
| |
JCO Aug 1 1991: 1426–1431.
[Abstract]
[PDF]
|
|
|
Double intensive consolidation chemotherapy in adult acute myeloid leukemia |
| |
JL Harousseau, N Milpied, J Briere, B Desablens, PY Leprise, N Ifrah, B Gandhour, and P Casassus |
| |
JCO Aug 1 1991: 1432–1437.
[Abstract]
[PDF]
|
|
|
Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid- Atlantic Oncology Program study |
| |
GL Wampler, WJ Heim, NM Ellison, JD Ahlgren, and JG Fryer |
| |
JCO Aug 1 1991: 1438–1445.
[Abstract]
[PDF]
|
|
|
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy [published erratum appears in J Clin Oncol 1991 Nov;9(11):2080] |
| |
J Prendiville, J Radford, N Thatcher, W Steward, M Ranson, P Burt, and R Stout |
| |
JCO Aug 1 1991: 1446–1452.
[Abstract]
[PDF]
|
|
|
A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer |
| |
R Cellerino, D Tummarello, F Guidi, P Isidori, M Raspugli, B Biscottini, and G Fatati |
| |
JCO Aug 1 1991: 1453–1461.
[Abstract]
[PDF]
|
|
|
Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer |
| |
SE Ettinghausen and ME Burt |
| |
JCO Aug 1 1991: 1462–1466.
[Abstract]
[PDF]
|
|
|
A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia |
| |
RP Warrell, Jr, WK Murphy, P Schulman, PJ O'Dwyer, and G Heller |
| |
JCO Aug 1 1991: 1467–1475.
[Abstract]
[PDF]
|
|
|
Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trial |
| |
SA Taylor, J Crowley, TW Pollock, HJ Eyre, C Jaeckle, HE Hynes, and RL Stephens |
| |
JCO Aug 1 1991: 1476–1479.
[Abstract]
[PDF]
|
|
|
Pharmacologically based dosing of etoposide: a means of safely increasing dose intensity |
| |
MJ Ratain, R Mick, RL Schilsky, NJ Vogelzang, and F Berezin |
| |
JCO Aug 1 1991: 1480–1486.
[Abstract]
[PDF]
|
|
|
A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study |
| |
PJ Stiff, RS McKenzie, LD Potempa, K Albain, D Koch, E Braud, VK Bansal, MK Weidner, VJ Lanzotti, and HG Chun |
| |
JCO Aug 1 1991: 1487–1494.
[Abstract]
[PDF]
|
|
|
Ifosfamide, Fanconi's syndrome, and rickets |
| |
CB Pratt, WH Meyer, JJ Jenkins, L Avery, CP McKay, RJ Wyatt, and ML Hancock |
| |
JCO Aug 1 1991: 1495–1499.
[Abstract]
[PDF]
|
|
|
Socioeconomic status and cancer survival |
| |
DF Cella, EJ Orav, AB Kornblith, JC Holland, PM Silberfarb, KW Lee, RL Comis, M Perry, R Cooper, and LH Maurer |
| |
JCO Aug 1 1991: 1500–1509.
[Abstract]
[PDF]
|
|
| Intraperitoneal therapy in ovarian cancer: time's not up |
| FM Muggia and DS Alberts |
|
JCO Aug 1 1991: 1510–1511.
[PDF]
|
|
| Modulation of fluorouracil by methotrexate |
| JR Bertino |
|
JCO Aug 1 1991: 1511a–1512.
[PDF]
|
|
| Dose intensity and lymphoma |
| R Meyer, M Goodyear, and W Hryniuk |
|
JCO Aug 1 1991: 1511b.
[PDF]
|
|
| Efficacy of sequential methotrexate, fluorouracil, and leucovorin rescue: due to the 24-hour interval? The leucovorin-fluorouracil combination? Both? |
| DS Martin |
|
JCO Aug 1 1991: 1512–1513.
[PDF]
|
|
| Sequencing of noncrossresistant agents |
| JH Goldie |
|
JCO Aug 1 1991: 1513–1514.
[PDF]
|
|
| The treatment of stage IIIA Hodgkin's disease--total nodal irradiation versus combination chemotherapy: either or neither |
| AM Oza, M Leahy, J Lim, W Gregory, AG Stansfeld, PF Wrigley, and TA Lister |
|
JCO Aug 1 1991: 1514–1516.
[PDF]
|
|
